Efficacy of MRI and Mammography for Breast-Cancer Screening in Women with a Familial or Genetic Predisposition
Mieke Kriege, Jan G.M. Klijn(German Cancer Research Center), Rob A.�E.�M. Tollenaar(Leiden University Medical Center), Hans Peterse(The Netherlands Cancer Institute), Theo M. de Kok(Erasmus MC Cancer Institute), Sara Müller(Arthritis UK), Harry J. de Koning(Erasmus MC), C. Boetes(Radboud University Nijmegen), Emiel J. Rutgers(Oncode Institute), Cecile T.M. Brekelmans(Erasmus MC), L.V.A.M. Beex, Inge Marie Obdeijn, Madeleine M.A. Tilanus‐Linthorst(Erasmus University Rotterdam), Harmine M. Zonderland, Radu A. Manoliu, Sybren Meijer(Erasmus MC Cancer Institute), Jan C. Oosterwijk(University Medical Center Groningen), Peter E. Besnard
Cited by 1,691
Related Papers
American Cancer Society Guidelines for Breast Screening with MRI as an Adjunct to Mammography
|CA A Cancer Journal for Clinicians|2007|2.6k
70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer
|New England Journal of Medicine|2016|2k
Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015
|Annals of Oncology|2015|1.8k
De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017
|Annals of Oncology|2017|1.3k
Breast MRI: guidelines from the European Society of Breast Imaging
|European Radiology|2008|819